Friday, September 5, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Study identifies protein that helps COVID-19 virus evade immune system

July 16, 2024
in Cancer
Reading Time: 5 mins read
0
Study identifies protein that helps COVID-19 virus evade immune system
67
SHARES
613
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

An article published in the journal Cell describes a study that enabled a group of researchers to discover how SARS-CoV-2 evades the cytotoxic immune response by identifying a protein called ORF6 that is a key factor in this mechanism. 

Study identifies protein that helps COVID-19 virus evade immune system

Credit: Harvard Medical School’s Massachusetts General Hospital

An article published in the journal Cell describes a study that enabled a group of researchers to discover how SARS-CoV-2 evades the cytotoxic immune response by identifying a protein called ORF6 that is a key factor in this mechanism. 

The cytotoxic immune response involves T-lymphocytes that kill pathogens when they recognize cells bearing a specific antigen while sparing neighboring uninfected cells.

The study was led by Wilfredo Garcia-Beltran and Julie Boucau, research scientists at the Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard University in the United States. The first authors of the article are Marcella Cardoso, a Brazilian postdoctoral research fellow at Harvard Medical School (HMS) and MGH, and Jordan Hartmann, also of HMS. Scientists affiliated with institutions in Brazil and Germany also took part.

“We discovered that SARS-CoV-2 is able to evade detection by the immune system by diminishing the vestiges that point to the presence of the virus in cells. In this process, the virus disturbs certain proteins on the surface of infected cells to inhibit interaction between them and T-lymphocytes,” Cardoso explained.

Defense cells known as natural killers (NKs) are fundamental to detect and combat viruses. They are part of the innate immune response, the first barrier against infection. NKG2D, a protein expressed on the surface of NKs, recognizes and kills infected cells (and cancer cells) by targeting stress-induced ligands released by the infection, such as MIC-A and MIC-B. This recognition is essential for contaminated cells to be removed from the organism.

Systematic analysis of the proteins in SARS-CoV-2 led to the finding that ORF6 – unique to and conserved among mammalian sarbecoviruses (the subgenus of Coronaviridae to which the virus that causes COVID-19 belongs) – participates actively in the removal of these important signalers of infected cells, facilitating viral proliferation in the host organism.

Confirming this evasion mechanism, when MIC-A and MIC-B receptors were protected with 7C6, an antibody used as a “shield”, NKs were far more successful in finding and destroying infected cells. 

The co-authors of the article include four other Brazilians: Maria Cecília Ramiro, a PhD candidate at the State University of Campinas’s School of Medical Sciences (FCM-UNICAMP); and Fernanda Orsi, Lício Velloso and Erich de Paula, professors at FCM-UNICAMP.

According to De Paula, UNICAMP’s participation was linked to projects funded by FAPESP during the pandemic.

“Our group collaborated with the discussion of strategies and the sharing of a clinical cohort used to validate the data,” he said. 

De Paula was principal investigator for the project “Evaluation of the mechanisms of hemostatic activation in COVID-19 and their modulation by bradykinin inhibitors”. 

Velloso was principal investigator for the project “Clinical trial of bradykinin inhibition in hospitalized adults with severe COVID-19”, from which some of the clinical data and samples were obtained.

“Studies of the immune response in severe COVID-19 patients showed that this elimination of proteins also occurred in these cases. Data collected from patients during hospitalization were key to this cross-border research project, demonstrating the importance of the role of collaborative research with hospitals to contain pandemics in real time,” Cardoso said.

Samples collected at UNICAMP’s general and teaching hospital (Hospital de Clínicas) displayed greater diversity of clinical outcomes in response to the action of different strains of the virus. “In parallel, we conducted in vitro experiments in which lung tissue cells were infected with the live virus,” Cardoso said.

Monoclonal antibodies and new research fronts

In light of recent preclinical oncological trials showing that monoclonal antibody 7C6 can prevent elimination of MIC-A and -B (which stimulate NKs and T-cells), the researchers decided to see if it would also be effective to curtail evasion of the immune system by the virus.

“We expected this approach to not only stimulate elimination of infected cells but also increase co-stimulation of CD8+ T cells [lymphocytes of the adaptive immune system, often called cytotoxic T lymphocytes, or CTLs], thus activating both the innate and adaptive immune systems,” Cardoso explained. A series of experiments and in vitro assays were conducted to test the hypotheses.

“Knowing how SARS-CoV-2 and other coronaviruses affect these proteins and how this influences the immune response helps us understand better how they interact with the body. It also helps identify possible targets for novel treatments to strengthen the immune system and combat viral infections,” Cardoso said.

The results open up research fronts in the field of host-directed antiviral therapies since the discovery of the role played by the antibody 7C6 in boosting the elimination of cells infected by SARS-CoV-2 also points to possible innovative therapeutic strategies. 

“Based on these results, it will be possible to conduct in vivo trials using transgenic animal models with the aim of evaluating the clinical applicability of the strategy. Further stages of the research are still needed, but the results are highly promising,” Cardoso said.

About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at www.fapesp.br/en and visit FAPESP news agency at www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.



Journal

Cell

DOI

10.1016/j.cell.2024.03.026

Article Title

Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses

Article Publication Date

22-Apr-2024

Share27Tweet17
Previous Post

Ruled by robots: Research reveals people prefer AI to make decisions

Next Post

Scientists use machine learning to predict diversity of tree species in forests

Related Posts

blank
Cancer

Natural Medicines Target Tumor Blood Vessels to Halt Cancer Progression

September 5, 2025
blank
Cancer

Cutting-Edge Oncolytic Virus and Immunotherapy Synergies Herald New Era in Cancer Treatment

September 5, 2025
blank
Cancer

Breakthroughs in In Vivo CAR T Cell Production Transforming Cancer Therapy

September 5, 2025
blank
Cancer

MD Anderson and Phoenix SENOLYTIX Forge Strategic Cross-Licensing Partnership to Advance Inducible Switch Technologies in Cell and Gene Therapies

September 5, 2025
blank
Cancer

Breakthrough Discoveries from MD Anderson: Research Highlights – September 5, 2025

September 5, 2025
blank
Cancer

Targeting One Key Factor Could Disrupt Brain Tumors in Two Crucial Ways

September 5, 2025
Next Post
Scientists use machine learning to predict diversity of tree species in forests

Scientists use machine learning to predict diversity of tree species in forests

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27544 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    959 shares
    Share 384 Tweet 240
  • Bee body mass, pathogens and local climate influence heat tolerance

    643 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    510 shares
    Share 204 Tweet 128
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Faith and Resilience: Strategies Against Cognitive Attacks
  • Improving Sleep in Shift-Work Nurses: A Meta-Analysis
  • Studying Soil Green Algae in Rubber Plantations
  • Natural Medicines Target Tumor Blood Vessels to Halt Cancer Progression

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.

Join 5,183 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine